Eicosanoid determination - Masoodi et al.

From LipidomicsWiki

(Redirected from Masoodi et al...)
Jump to: navigation, search


Contents

Analytes

  • 27 Eicosanoids:

PGD1; PGE1; PGF1α; 6-keto-PGF1α; PGB2; PGD2; PGE2; PGF2α; PGJ2; 12-PGJ2; 15-desoxy-∆12,14-PGJ2; PGD3; PGE3; PGF3α; TXB2; TXB3; 8-iso-PGE2; 8-iso-15-keto-PGE2; 8-iso-PGF2α; 8-iso-15-keto-PGF2α; 13,14-dihydro-PGE1; 13,14-dihydro-15-keto-PGE1; 13,14-dihydro-PGF1α; 13,14-dihydro-15-keto-PGF1α; 13,14-dihydro-15-keto-PGE2; 13,14-dihydro-PGF2α; 13,14-dihydro-15-keto-PGF2α;

  • 1 Internal Standard (IS):

PGB2-d4

Sample Preparation

  • homogenisation of tissue samples (in H2O)
  • adjust to 15 % MeOH (final volume: 3 ml)
  • addition of 40 ng PGB2-d4 (IS)
  • incubation (on ice, 30 min)
  • centrifugation (3000 rpm, 5 min)
  • acidification (0.1 M HCl; pH = 3.0)

SPE

column equilibration wash elution
C18-E

(500 mg, 6 ml, Phenomenex)

20 ml MeOH; 20 ml H2O 200 μl MeOH (10 %); 20 ml H2O; 10 ml Hexan 15 ml HCOOMe
  • evaporation of solvents
  • addition of 100 μl EtOH (stored at -20 °C)
Material Material used Internal Standard(s) Internal Standard(s) added
rat brain tissue
rat liver tissue
rat plasma
rat urine

Instrumentation and Method

Autosampler

  • Type: 2690 (Waters)
  • Injection volume: 5 μl
  • Wash solvent: n.d.
  • T (autosampler chamber): 8 °C

HPLC

  • Type: Alliance 2695 (Waters)
  • Column: Gemini C-18 (2.0 * 150 mm, 5 μl, Phenomenex)
  • T column: n.d.
  • Solvents:
A: CH3CN / H2O / CH3COOH (45 / 55 / 0.02)
B: CH3CN / H2O / CH3COOH (90 / 10 / 0.02)
  • Gradient:
Time [min] Flow [ml/min]  % Solvent A  % Solvent B
0-8 0,2 100 0
8,1-12 0,2 50 50
12,1-20 0,2 30 70
20,1-30 0,2 100 0
  • Run time: 30 min (10 min wash cycle included)

Mass Spectrometer

  • Type: triple quadrupole Quattro Ultima MS (Waters)
  • Ionization mode: ESI negative
  • Capillary voltage: 3500 V
  • T (source): 120 °C
  • T (desolvation): 360 °C
  • Cone voltage: 35 V
  • MS/MS-conditions:
    • Scan modi: Q1, MS2, MRM
    • Collision energy: optimized (12 - 38 eV)
    • Dwell time: 0.2 s
    • MRM table:
Analyte MRM [m/z] Collision energy [eV]
PGD1 353 -> 317 15
PGE1 353 -> 317 15
PGF1α 355 -> 311 25
6-keto-PGF1α 369 -> 163 23
PGB2 333 -> 175 20
PGB2-d4 337 -> 179 20
PGD2 351 -> 271 17
PGE2 351 -> 271 17
PGF2α 353 -> 193 25
PGJ2 333 -> 271 15
Δ 12-PGJ2 333 -> 271 15
15-deoxy-Δ 12,14-PGJ2 315 -> 271 15
PGD3 349 -> 269 15
PGE3 349 -> 269 15
PGF3α 351 -> 193 25
TXB2 369 -> 169 17
TXB3 367 -> 169 15
8-iso-PGE2 351 -> 315 15
8-iso-15-keto-PGE2 349 -> 113 23
8-iso-PGF2α 353 -> 193 25
8-iso-15-keto-PGF2α 351 -> 315 15
13,14-dihydro-PGE1 355 -> 337 15
13,14-dihydro-15-keto-PGE1 353 -> 335 12
13,14-dihydro-PGF1α 357 -> 113 38
13,14-dihydro-15-keto-PGF1α 355 -> 193 32
13,14-dihydro-15-keto-PGE2 351 -> 333 12
13,14-dihydro-PGF2α 355 -> 311 30
13,14-dihydro-15-keto-PGF2α 353 -> 113 28

Data analysis and quantification

Data handling

Isotope correction

Calibration and quantification

Method Validation

Accuracy

Precision

LOD

n.d.

LOQ

n.d.

Recovery

Linearity

n.d.

Reference

Contact

  • School of Pharmacy; University of Bradford; Richmond Road; Bradford BD7 1DP; UK.
  • e-mail: a.nicolaou@bradford.ac.uk
Personal tools
Create a book